Medication History: quick answer用药史：快速回答
A medication history is evidence gathering. It becomes medication reconciliation only when compared with current orders and discrepancies are resolved at a transition of care.
用药史记录的是某一时间范围内患者实际使用了什么，以及每项陈述由什么来源支持。相关资料应保留来源、时间和待确认问题，诊断或治疗判断仍由医疗专业人员负责。
Evidence model for medication history用药史所需证据模型
A medication history records what a person actually used over a defined period and how each statement is supported. For every prescription, nonprescription product, supplement, inhaler, injection, patch, cream, eye or ear preparation, and relevant as-needed medicine, capture ingredient, product, strength, dose, route, schedule, indication, start and stop dates, last dose, prescriber or source, adherence pattern, observed benefit, suspected reaction, and confidence. Keep conflicting sources side by side until a professional resolves them.
用药史记录的是某一时间范围内患者实际使用了什么，以及每项陈述由什么来源支持。处方药、非处方药、补充剂、吸入剂、注射剂、贴剂、外用药、眼耳制剂和相关按需药物，都应记录成分、产品、规格、剂量、途径、频次、适应证、起止日期、末次用药、处方者或来源、依从性、观察到的获益、疑似反应和可信程度。来源冲突在专业人员解决前应并列保留。
A worked medication history scenario用药史工作示例
A patient portal list, pharmacy fill record, medication bottles, and interview disagree about a medicine. The record preserves each source and marks the current status as unconfirmed until a professional resolves it. This is a hypothetical workflow example, not an individual clinical recommendation or a product-performance claim.
假设示例：患者门户、药房配药记录、随身药盒和访谈对同一种药的剂量说法不一致。整理人员分别记录四个来源及日期，把门户中的旧医嘱标为历史记录，把患者自述标为待确认的实际用法，并请药师或处方医生核实。最终清单保留冲突解决过程，而不是覆盖掉较早的信息。该示例只说明工作流，不构成个体化临床建议或产品效果声明。
Where medication history fits用药史的适用范围
Patients preparing records, clinicians, pharmacists, nurses, and health information staff use medication history to build a source-attributed, time-aware account of what a person actually used rather than copying a single current list. The working evidence includes prescription and nonprescription medicines, supplements, dose, route, schedule, indication, start and stop dates, adherence, reactions, and evidence sources. These boundaries determine what a useful output must contain and which conclusions require professional review.
用药史由相应临床、数据、信息管理和治理人员共同参与。相关资料需组织成可追溯、可复核的结果，并明确数据边界、不确定性、待确认问题与最终责任人。
Patients preparing records, clinicians, pharmacists, nurses, and health information staff.
应由具有相应职责和专业范围的人员完成最终解释与确认。
Build a source-attributed, time-aware account of what a person actually used rather than copying a single current list.
输出应保留来源、时间、不确定性、待确认问题和处置责任。
How to carry out medication history如何执行用药史
- Step 1. Define the history period and the clinical purpose for collecting it.
- Step 2. Interview the patient or caregiver using open questions before prompting by category.
- Step 3. Compare containers, pharmacy records, EHR lists, discharge papers, and specialist letters.
- Step 4. Resolve product identity and preserve disagreements about dose, status, or dates.
- Step 5. Publish an as-of medication history with source labels, uncertainty, and reviewer name.
- 第 1 步。明确用药史覆盖期间和收集目的。
- 第 2 步。先用开放式问题访谈患者或照护者，再按类别提示补充。
- 第 3 步。比对药盒、药房记录、电子病历清单、出院文件和专科信件。
- 第 4 步。确认产品身份，并保留剂量、状态或日期上的分歧。
- 第 5 步。形成带有截至日期、来源标签、不确定性和复核者姓名的用药史。
Working note 1. Begin by making the first action operational: define the history period and the clinical purpose for collecting it. Name the person who can confirm scope, the time cutoff, the source systems that count, and the conditions that place a record outside the source-attributed medication review. For medication history, a clear entry rule prevents a convenient dataset from silently replacing the intended population or clinical question. Preserve rejected records with a reason code so qualified assessors can distinguish a deliberate exclusion from a missing or failed import.
Working note 2. The second action is evidence control: interview the patient or caregiver using open questions before prompting by category. Preserve when each item happened, when it became available, who entered or supplied it, whether it is preliminary or final, and how corrections are represented. The relevant material may include prescription and nonprescription medicines, supplements, dose, route, schedule, indication, start and stop dates, adherence, reactions, and evidence sources. Do not collapse two values merely because their labels look alike. A reviewer is expected to be able to return from a normalized field to the original record and understand every transformation in between.
Working note 3. At the third action, compare containers, pharmacy records, ehr lists, discharge papers, and specialist letters. Set out the expected intermediate artifact before processing starts: a compared list, time-aligned cohort, mapped event, scored observation, or another output appropriate to medication history. Leave visible conflicts and uncertainty visible. When a source is incomplete, the review path is expected to say whether the item is excluded, retained with a flag, estimated under a declared rule, or sent for clarification; silent imputation can make a clean result clinically misleading.
Working note 4. The fourth action requires contextual interpretation: resolve product identity and preserve disagreements about dose, status, or dates. Separate what the records directly show from what the working group infers, and record plausible alternative explanations. The objective is to build a source-attributed, time-aware account of what a person actually used rather than copying a single current list, not to convert a pattern into an unsupported diagnosis, causal claim, or treatment instruction. Reviewers is expected to see the denominator, comparison point, timing assumptions, and exceptions that could change the meaning of the produced evidence before any operational or clinical response is considered.
Working note 5. Close the cycle through the fifth action: publish an as-of medication history with source labels, uncertainty, and reviewer name. Assign every unresolved item to a named role, define the response time, and record the final disposition without deleting the earlier state. The handoff is expected to include the source cutoff, version, material exceptions, validation status, and next review date. This makes medication history reproducible when another qualified member of patients preparing records, clinicians, pharmacists, nurses, and health information staff needs to reconstruct why the produced evidence was accepted, challenged, corrected, or left unresolved.
执行说明 1。首先把第一项行动落实为可执行规则：明确用药史覆盖期间和收集目的。需要明确谁有权确认范围、资料截止时间、哪些来源有效，以及什么条件会让记录不进入复核。对于用药史，清晰的入口规则可以防止方便取得的数据悄然替代真正的人群或临床问题。被排除的记录仍应保留原因代码，使复核者能够区分主动排除、资料缺失和导入失败。
执行说明 2。第二项行动关注证据控制：先用开放式问题访谈患者或照护者，再按类别提示补充。每项资料都要记录事件发生时间、可用时间、录入或提供者、初步或最终状态，以及修订如何表示。相关资料必须覆盖用药史所需的来源、时间、状态、编码、单位和上下文。不能因为标签相似就合并两个数值；复核者应能从规范化字段回到原始记录，并理解中间每一步转换。
执行说明 3。第三项行动是比对药盒、药房记录、电子病历清单、出院文件和专科信件。处理开始前，应先定义符合用药史需要的中间成果，例如对照清单、时间对齐人群、映射事件或带来源的观察结果。冲突和不确定性必须可见。来源不完整时，流程应说明是排除、带标记保留、按已声明规则估计，还是转交确认；静默填补可能让整洁结果产生错误临床含义。
执行说明 4。第四项行动要求结合背景解释：确认产品身份，并保留剂量、状态或日期上的分歧。应区分记录直接显示的事实和团队作出的推断，并保留其他合理解释。目标是支持用药史所界定的资料整理、分析和复核任务，而不是把模式直接写成未经支持的诊断、因果结论或治疗指令。在采取运营或临床响应前，复核者需要看到分母、比较点、时间假设和可能改变结论的例外。
执行说明 5。第五项行动用于闭环：形成带有截至日期、来源标签、不确定性和复核者姓名的用药史。每个未解决项目都要分配给明确角色，规定响应时间，并在不删除先前状态的情况下记录最终处置。交接材料应包含来源截止时间、版本、重要例外、验证状态和下次复核日期，使另一位合格人员能够重建为何结果被接受、质疑、纠正或继续保持未解决。
Review gates for medication history用药史复核关口
| Review gate复核关口 | Topic-specific question本主题问题 | Expected evidence预期证据 |
|---|---|---|
| Identity and scope身份与范围 | Does the record match the intended people, setting, and time window for medication history?记录是否符合用药史所需的人群、场景和时间范围？ | Source register and dated inclusion rules来源登记与带日期的纳入规则 |
| Meaning含义 | Can the team distinguish the evidence needed to build a source-attributed, time-aware account of what a person actually used rather than copying a single current list?团队能否区分完成本主题任务所需的不同证据？ | Field definitions, status, provenance, and sampled source records字段定义、状态、来源和抽样原始记录 |
| Professional review专业复核 | Are uncertainty, exceptions, and the accountable reviewer visible?不确定性、例外和责任复核者是否清晰？ | Review note, disposition, and unresolved-question list复核记录、处置意见和待确认问题清单 |
| Acceptance验收 | Do the topic-specific measures show that the workflow is usable and reproducible?本主题指标能否证明流程可用且可复现？ | Versioned result, validation sample, and correction log版本化结果、验证样本和纠错日志 |
Interpret medication history without losing context在不丢失背景的情况下解释用药史
Ask about behavior without treating imperfect use as noncompliance. People may split tablets, vary timing around work or meals, use an inhaler differently from the order, stop a medicine after a reaction, or obtain products outside the main health system. Record intended use and reported use as separate facts. Approximate dates should remain approximate, and a dispensing record should be described as evidence of supply rather than proof that every dose was taken.
询问实际行为时，不应把不完全按计划使用简单归为“不依从”。患者可能掰片、因工作或进餐改变时间、采用与医嘱不同的吸入方式、出现反应后停药，或从主要医疗体系之外获得产品。计划用法和自述用法应作为不同事实记录；估算日期应保持为估算，配药记录只能证明供应，不能证明每一剂都已服用。
Validation and operating measures for medication history用药史的验证与运行指标
Review quality by source coverage, proportion of medicines with complete dose and route, percentage with a confirmed current status, unresolved discrepancies, high-risk products without monitoring information, and time since last verification. Sample records against original documents and patient interviews. A history is ready for downstream use only when its date, scope, sources, uncertainty, and reviewer are visible; otherwise label it preliminary rather than silently treating it as current.
质量检查可关注来源覆盖率、剂量和途径完整的药物比例、当前状态已确认比例、未解决差异、缺少监测信息的高风险药物，以及距上次确认的时间。应抽样回查原始文件和访谈记录。只有当日期、范围、来源、不确定性和复核者均清晰时，用药史才适合后续使用；否则应标记为初步记录，不能默认视为当前清单。
Failure modes and limits of medication history用药史的失败模式与限制
Recall can be incomplete, brand names can hide ingredients, old EHR lists may appear current, and refill data can lag or omit cash purchases. A history also does not explain whether every medicine remains indicated or whether a discrepancy is intentional. Those questions belong to medication reconciliation or clinical medication review. Protect sensitive information, verify identity before merging records, and never infer a stop date merely because a product disappears from one source.
回忆可能不完整，商品名可能隐藏成分，旧电子病历清单可能看起来仍在使用，续配数据也可能延迟或遗漏自费购买。用药史本身不能回答每种药是否仍有适应证，也不能判断差异是否有意；这些问题属于用药核对或临床用药评估。合并记录前应核验身份、保护敏感信息，并且不能因为某药从一个来源消失就推断其停用日期。
Organized records and tool output support trend recognition and professional decisions. Drug interactions, risk predictions, diagnoses, and treatment conclusions require qualified medical review.
整理后的资料和工具输出仅用于趋势识别和专业决策辅助。药物相互作用、风险预测、诊断与治疗结论必须由合格医疗专业人员审核。
Operate medication history as a controlled workflow把用药史作为受控工作流运行
Turn medication history into a written operating brief before configuring a dashboard, rule, model, or review queue. Name the intended users—patients preparing records, clinicians, pharmacists, nurses, and health information staff—and state the decision, time available, acceptable uncertainty, and consequence of a delayed or incorrect result. The brief is expected to use the bounded objective to build a source-attributed, time-aware account of what a person actually used rather than copying a single current list. Requests such as “show insights” or “find risk” are not testable until the population, event, time window, owner, and permitted action are explicit.
Create a source register for prescription and nonprescription medicines, supplements, dose, route, schedule, indication, start and stop dates, adherence, reactions, and evidence sources. For every source, document its steward, collection process, event time, availability time, status model, code or unit system, revision behavior, coverage, and known gaps. Then connect the first two workflow actions—define the history period and the clinical purpose for collecting it and interview the patient or caregiver using open questions before prompting by category—to named fields and documents. This prevents a familiar label from being treated as equivalent across systems when the underlying event or meaning is different.
Build test records before full use of medication history. Include ordinary cases, missing fields, duplicate identities, conflicting sources, late events, corrected values, unusual but valid states, and records that is expected to not enter the review path. Use the middle action, compare containers, pharmacy records, ehr lists, discharge papers, and specialist letters, to define expected results for each case. Leave visible the expected professional explanation beside the technical expectation so a passing transformation does not conceal an interpretation error.
Separate technical acceptance from domain acceptance. Technical review shows that inputs arrive, mappings run, calculations reproduce, permissions work, and failures are visible. Domain review asks whether the information has the correct meaning for medication history, reaches the intended professional at the right moment, and supports a safe response. The later workflow actions—resolve product identity and preserve disagreements about dose, status, or dates and publish an as-of medication history with source labels, uncertainty, and reviewer name—is expected to be demonstrated in the real interface rather than inferred from a data extract.
Set out correction, escalation, and change control before launch. Users need a route to challenge a result, repair a source or mapping, annotate an exception, and determine which prior outputs are affected. Version the source contract, terminology, logic, thresholds, display, and review policy. When any material element changes, compare new and previous results on representative records, decide whether earlier medication history outputs remain valid, and document who approved the release and who can roll it back.
The final medication history handoff is expected to let another qualified reviewer understand and reproduce the produced evidence without relying on undocumented team knowledge. Include the purpose, inclusion rules, source inventory, data cutoff, original evidence links, transformations, workflow state, exceptions, validation results, reviewer disposition, and unresolved questions. Add the specific evidence used to build a source-attributed, time-aware account of what a person actually used rather than copying a single current list, identify which statements are observed versus inferred, and state the next review date. Sensitive details is expected to remain only in approved systems with role-appropriate access and retention.
在配置仪表板、规则、模型或复核队列前，应先把用药史写成运行说明。明确目标用户、支持的决策、可用时间、可接受不确定性，以及延迟或错误结果的后果。说明中必须写清人群、事件、时间窗口、责任人和允许采取的行动；“寻找洞察”或“发现风险”等宽泛要求无法直接测试和验收。
针对用药史所需资料建立来源登记表。每个来源都应记录数据责任人、采集过程、事件时间、可用时间、状态模型、编码或单位体系、修订方式、覆盖范围和已知缺口。随后把前两个工作步骤——明确用药史覆盖期间和收集目的和先用开放式问题访谈患者或照护者，再按类别提示补充——落实到具体字段和文档，防止把名称相似但事件含义不同的数据直接视为等价。
全面使用用药史前应建立测试记录，覆盖普通情况、字段缺失、身份重复、来源冲突、事件延迟、数值修订、少见但有效的状态，以及本来不应进入流程的记录。围绕“比对药盒、药房记录、电子病历清单、出院文件和专科信件”为每个测试病例写出预期结果，并把专业解释与技术预期放在一起，避免技术转换通过却隐藏解释错误。
技术验收和领域验收必须分开。技术复核证明输入到达、映射运行、计算可复现、权限有效且失败可见；领域复核则确认信息对用药史含义正确、在合适时间到达目标专业人员并支持安全响应。后两个步骤——确认产品身份，并保留剂量、状态或日期上的分歧和形成带有截至日期、来源标签、不确定性和复核者姓名的用药史——应在真实界面和工作流中演示，不能只从数据抽取结果推断。
上线前定义纠错、升级和变更控制。使用者需要能够质疑结果、修复来源或映射、标注例外，并判断哪些既往输出受到影响。来源合同、术语、逻辑、阈值、显示和复核制度都应进行版本管理；任何重大变化后，都要在代表性记录上比较新旧结果，判断既往用药史输出是否仍有效，并记录批准者和回滚责任人。
最终用药史交接包应让另一位合格复核者无需依赖团队未记录的知识，就能理解并复现结果。材料应包含目的、纳入规则、来源清单、数据截止时间、原始证据链接、转换过程、工作流状态、例外、验证结果、复核处置和待确认问题；还要区分观察与推断、说明下次复核日期，并把敏感详情限制在具有适当访问和保留控制的获批系统中。
Prepare medication history evidence with 医数智析用医数智析准备用药史资料
Before opening the workspace, prepare prescription and nonprescription medicines, supplements, dose, route, schedule, indication, start and stop dates, adherence, reactions, and evidence sources. 医数智析 can help organize those materials into a longitudinal record, expose missing or conflicting entries, and make cross-time patterns available for professional review. Final clinical interpretation remains with qualified professionals.
打开工作区前，请准备与用药史直接相关的原始资料、日期和来源。医数智析可帮助整理纵向记录、暴露缺失或冲突，并把跨时间变化呈现给专业人员复核；最终临床解释仍由合格专业人员负责。
View the 医数智析 tool page查看医数智析工具页 Open the live experience打开实际体验页Medication History questions用药史常见问题
Yes. Include prescription medicines, over-the-counter products, vitamins, supplements, inhaled or injected products, topical medicines, and as-needed use because each may affect review.
应该。处方药、非处方药、维生素、补充剂、吸入或注射产品、外用药以及按需使用都可能影响专业复核，因此应一并记录。
No. It shows that a product was supplied, but it does not prove when or how it was taken. Combine fill data with interview and clinical records.
不等同。它能证明药物曾被供应，但不能证明患者何时、如何服用，应结合访谈和临床记录。
Update it whenever medicines change and re-verify it at important encounters or transitions. Always display the last-confirmed date so readers know how current it is.
每次用药变化后都应更新，并在重要就诊或照护转换时重新确认；清单上必须显示最近确认日期。
Primary source for medication history用药史的主要参考来源
Use the cited primary or official source together with current organizational policy and the professional standards that apply in the intended setting.
实施时应把下列第一方或权威来源与当前机构制度及适用专业标准结合使用。